{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:32:08Z","timestamp":1791937928047,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cll.2021.07.007","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T02:38:51Z","timestamp":1632883131000},"page":"647-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Granulocyte Transfusion"],"prefix":"10.1016","volume":"41","author":[{"given":"Tobias","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra C.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy P.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Staley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2021.07.007_bib1","series-title":"Transfusion therapy: clinical principles and practice","first-page":"149","article-title":"Granulocyte transfusion","author":"Tanhehco","year":"2019"},{"issue":"2","key":"10.1016\/j.cll.2021.07.007_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/514550","article-title":"Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials","volume":"25","author":"Elting","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.cll.2021.07.007_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00277-014-2086-0","article-title":"Management of sepsis in neutropenic patients: 2014 updated guidelines from the infectious diseases working party of the German Society of Hematology and Medical Oncology (AGIHO)","volume":"93","author":"Penack","year":"2014","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.cll.2021.07.007_bib4","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jcyt.2017.08.012","article-title":"Granulocyte transfusions: a concise review for practitioners","volume":"19","author":"Gea-Banacloche","year":"2017","journal-title":"Cytotherapy"},{"issue":"10","key":"10.1016\/j.cll.2021.07.007_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/bmt.2008.237","article-title":"Randomized phase III study of granulocyte transfusions in neutropenic patients","volume":"42","author":"Seidel","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"18","key":"10.1016\/j.cll.2021.07.007_bib6","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone-treated donors in neutropenic patients with infection","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2021.07.007_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1101(1996)11:1<1::AID-JCA1>3.0.CO;2-F","article-title":"Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis","volume":"11","author":"Vamvakas","year":"1996","journal-title":"J\u00a0Clin Apher"},{"issue":"2","key":"10.1016\/j.cll.2021.07.007_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1098-1101(1997)12:2<74::AID-JCA4>3.0.CO;2-6","article-title":"Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis","volume":"12","author":"Vamvakas","year":"1997","journal-title":"J\u00a0Clin Apher"},{"key":"10.1016\/j.cll.2021.07.007_bib9","series-title":"Principles of transfusion medicine","first-page":"281","article-title":"Granulocyte transfusions","author":"Strauss","year":"1996"},{"issue":"5","key":"10.1016\/j.cll.2021.07.007_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000492629","article-title":"An International registry of granulocyte transfusions","volume":"45","author":"Pagano","year":"2018","journal-title":"Transfus Med Hemother"},{"issue":"3","key":"10.1016\/j.cll.2021.07.007_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2141.2012.09190.x","article-title":"Role of granulocyte\/neutrophil transfusions for haematology\/oncology patients in the modern era","volume":"158","author":"Strauss","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cll.2021.07.007_bib12","unstructured":"Granulocyte Components. In: AABB, Cross AR, Centers AsB, Program ASB, eds Circular of Information for the use of Human Blood and Blood Components. 2017. p. 41\u20134."},{"issue":"11","key":"10.1016\/j.cll.2021.07.007_bib13","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1046\/j.1537-2995.2002.00249.x","article-title":"Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors","volume":"42","author":"H\u00fcbel","year":"2002","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.cll.2021.07.007_bib14","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1537-2995.2012.03904.x","article-title":"A\u00a0comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010","volume":"53","author":"Dorsey","year":"2013","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.cll.2021.07.007_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1182\/hematology.2020000135","article-title":"Does ABO and RhD matching matter for platelet transfusion?","volume":"2020","author":"Dunbar","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.cll.2021.07.007_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.transci.2009.10.013","article-title":"ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies","volume":"42","author":"Josephson","year":"2010","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.cll.2021.07.007_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1537-2995.1997.37297203521.x","article-title":"A\u00a0comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers","volume":"37","author":"Liles","year":"1997","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.cll.2021.07.007_bib18","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1537-2995.2001.41081037.x","article-title":"Administration of G--CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G--CSF alone","volume":"41","author":"Stroncek","year":"2001","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.cll.2021.07.007_bib19","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1046\/j.1537-2995.2001.41121464.x","article-title":"Cataracts in neutrophil donors stimulated with adrenal corticosteroids","volume":"41","author":"Ghodsi","year":"2001","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.cll.2021.07.007_bib20","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1537-2995.2005.00594.x","article-title":"The risk of posterior subcapsular cataracts in granulocyte donors","volume":"45","author":"Burch","year":"2005","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.cll.2021.07.007_bib21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1537-2995.2010.02948.x","article-title":"Prevalence of posterior subcapsular cataracts in volunteer cytapheresis donors","volume":"51","author":"Clayton","year":"2011","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.cll.2021.07.007_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1537-2995.2008.01983.x","article-title":"Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone","volume":"49","author":"Quillen","year":"2009","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.cll.2021.07.007_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/bmt.2014.278","article-title":"A\u00a0review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies","volume":"50","author":"Shaw","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.cll.2021.07.007_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-3148.2012.01152.x","article-title":"The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma","volume":"22","author":"Massey","year":"2012","journal-title":"Transfus Med"},{"issue":"12","key":"10.1016\/j.cll.2021.07.007_bib25","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/j.1537-2995.2012.03661.x","article-title":"Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy","volume":"52","author":"Ikemoto","year":"2012","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.cll.2021.07.007_bib26","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1111\/trf.13795","article-title":"Use of hydroxyethyl starch in leukocytapheresis procedures does not increase renal toxicity","volume":"56","author":"Pagano","year":"2016","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.cll.2021.07.007_bib27","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1097\/MPH.0b013e3182580d40","article-title":"Granulocyte transfusion therapy in pediatric patients after hematopoietic stem cell transplantation: a 5-year single tertiary care center experience","volume":"34","author":"Pham","year":"2012","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.cll.2021.07.007_bib28","first-page":"9","article-title":"Function of granulocytes collected for transfusion","volume":"88","author":"Strauss","year":"1982","journal-title":"Prog Clin Biol Res"},{"issue":"5","key":"10.1016\/j.cll.2021.07.007_bib29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3324\/haematol.2015.136630","article-title":"Impaired killing of Candida albicans by granulocytes mobilized for transfusion purposes: a role for granule components","volume":"101","author":"Gazendam","year":"2016","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.cll.2021.07.007_bib30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1537-2995.2000.40040414.x","article-title":"Functional characteristics of neutrophils collected and stored after administration of G-CSF","volume":"40","author":"Leavey","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.cll.2021.07.007_bib31","first-page":"CD005339","article-title":"Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction","volume":"4","author":"Estcourt","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cll.2021.07.007_bib32","series-title":"Transfusion medicine and hemostasis: clinical and laboratory aspects","article-title":"Granulocyte transfusions","author":"Arinsburg","year":"2019"},{"key":"10.1016\/j.cll.2021.07.007_bib33","series-title":"Transfusion therapy: clinical principles and practice","first-page":"133","article-title":"Granulocyte transfusion therapy","author":"Strauss","year":"2010"},{"issue":"3","key":"10.1016\/j.cll.2021.07.007_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jca.2920100303","article-title":"Clinical perspectives of granulocyte transfusions: efficacy to date","volume":"10","author":"Strauss","year":"1995","journal-title":"J\u00a0Clin Apher"},{"issue":"2 Pt 1","key":"10.1016\/j.cll.2021.07.007_bib35","first-page":"281","article-title":"Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis","volume":"120","author":"Cairo","year":"1992","journal-title":"J\u00a0Pediatr"},{"issue":"10","key":"10.1016\/j.cll.2021.07.007_bib36","first-page":"CD003956","article-title":"Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia","author":"Pammi","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.cll.2021.07.007_bib37","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2017.02.026","article-title":"Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: the NIH experience","volume":"140","author":"Marciano","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.cll.2021.07.007_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-96-2-149","article-title":"The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation","volume":"96","author":"Hersman","year":"1982","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1016\/j.cll.2021.07.007_bib39","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1182\/blood-2011-02-335901","article-title":"West Nile virus infection transmitted by granulocyte transfusion","volume":"117","author":"Meny","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2021.07.007_bib40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-3476(78)80517-4","article-title":"Acute leukemia and granulocyte transfusion: fatal graft-versus-host reaction following transfusion of cells obtained from normal donors","volume":"93","author":"Rosen","year":"1978","journal-title":"J\u00a0Pediatr"},{"issue":"20","key":"10.1016\/j.cll.2021.07.007_bib41","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM198105143042001","article-title":"Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions","volume":"304","author":"Wright","year":"1981","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.cll.2021.07.007_bib42","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.0041-1132.2003.00568.x","article-title":"TRALI after the transfusion of cross-match-positive granulocytes","volume":"43","author":"Sachs","year":"2003","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.cll.2021.07.007_bib43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ajh.2830330405","article-title":"Effect of histocompatibility factors on pulmonary retention of indium-111-labeled granulocytes","volume":"33","author":"Dutcher","year":"1990","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.cll.2021.07.007_bib44","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1537-2995.2010.02993.x","article-title":"The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort","volume":"51","author":"Heim","year":"2011","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.cll.2021.07.007_bib45","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/trf.14551","article-title":"WBC alloimmunization: effects on the laboratory and clinical endpoints of therapeutic granulocyte transfusions","volume":"58","author":"Price","year":"2018","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.cll.2021.07.007_bib46","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1537-2995.2011.03195.x","article-title":"Alloimmunization and granulocyte transfusion: a new study confirms old lessons","volume":"51","author":"McCullough","year":"2011","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.cll.2021.07.007_bib47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/MOH.0000000000000189","article-title":"Neutrophil\/granulocyte transfusions collected from G-CSF\u200a+\u200adexamethasone-stimulated donors","volume":"22","author":"Strauss","year":"2015","journal-title":"Curr Opin Hematol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271221000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271221000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:57:13Z","timestamp":1759449433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271221000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0272271221000512"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2021.07.007","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granulocyte Transfusion","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2021.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}